J.P. Bergerat
About
In The Last Decade
J.P. Bergerat
27 papers receiving 307 citations
Peers
Comparison fields: 5 of 58
- Oncology 192
- Cancer Research 103
- Pulmonary and Respiratory Medicine 88
- Molecular Biology 72
- Pathology and Forensic Medicine 47
Countries citing papers authored by J.P. Bergerat
This map shows the geographic impact of J.P. Bergerat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Bergerat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Bergerat more than expected).
Fields of papers citing papers by J.P. Bergerat
This network shows the impact of papers produced by J.P. Bergerat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Bergerat. The network helps show where J.P. Bergerat may publish in the future.
Co-authorship network of co-authors of J.P. Bergerat
This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Bergerat. A scholar is included among the top collaborators of J.P. Bergerat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Bergerat. J.P. Bergerat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Duration of adjuvant trastuzumab treatment in routine practice. | 11 |
| 2 | 15 | |
| 3 | 7 | |
| 4 | 8 | |
| 5 | 47 | |
| 6 | 66 | |
| 7 | [Pharmacokinetic profile of high-dose doxorubicin administered during a 6 h intravenous infusion in breast cancer patients]. | 13 |
| 8 | 2 | |
| 9 | 19 | |
| 10 | 2 | |
| 11 | Cancer du sein après maladie de Hodgkin. Analyse de 6 observations. | 0 |
| 12 | Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen. | 2 |
| 13 | Hautes doses d'alkylants et autogreffe de moelle dans les cancers de l'ovaire à mauvais pronostic : une analyse rétrospective de 40 patientes traitées en France | 0 |
| 14 | 55 | |
| 15 | 4 | |
| 16 | 3 | |
| 17 | 7 | |
| 18 | 1 | |
| 19 | Choriocarcinome médiastinal au cours de l'évolution d'une leucose aiguë myeloblastique. | 1 |
| 20 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.